Filter Results
:
(115)
Show Results For
-
All HBS Web
(115)
- News (42)
- Research (57)
- Multimedia (1)
- Faculty Publications (37)
Show Results For
-
All HBS Web
(115)
- News (42)
- Research (57)
- Multimedia (1)
- Faculty Publications (37)
The a2 Milk Company
The a2 Milk Company (a2MC) became the most valuable company listed on the New Zealand stock exchange in 2018 by capitalizing on a biochemical discovery related to the protein composition of cow’s milk--cows naturally produce two types of beta casein proteins (A1 and...
View Details
- 09 Apr 2019
- First Look
New Research and Ideas, April 9, 2019
After a first year of trial rollout in Israel, CEO Lihi Segal and her team are devising a global go-to-market plan for the firm. The team is considering several target markets, ranging from people with diabetes to professional athletes,...
View Details
Keywords:
Dina Gerdeman
- Article
Navy Medicine Introduces Value-Based Health Care
By: Alee Hernandez, Robert S. Kaplan, Mary L. Witkowski, C. Forrest Faison III and Michael E. Porter
In 2016 the newly appointed surgeon general of the Navy launched a value-based health care pilot project at Naval Hospital Jacksonville to explore whether multidisciplinary care teams (known as integrated practice units, or IPUs) and measurement of outcomes could...
View Details
Hernandez, Alee, Robert S. Kaplan, Mary L. Witkowski, C. Forrest Faison III, and Michael E. Porter. "Navy Medicine Introduces Value-Based Health Care." Health Affairs 38, no. 8 (August 2019): 1393–1400.
- Web
Faculty & Advisors - MBA
is the designer and chairman of the T1D Fund, an impact investment fund he co-founded in 2016 that has used a venture philanthropic model to catalyze over $700 million of private capital investment in type one diabetes (T1D) cure...
View Details
- 15 Mar 2024
- HBS Case
Let's Talk: Why It's Time to Stop Avoiding Taboo Topics at Work
for Ozempic, the costly medicine for diabetes that is often used off-label for weight loss. “We don’t have 1,000 people with diabetes all of a sudden, but we can’t go have that conversation with them because...
View Details
Keywords:
by Avery Forman
- Web
South Asia - Global
Nordisk was owned by a charitable foundation, and since its founding in the 1920s had focused on producing insulin to treat diabetes. In 2017, however, it released Ozempic, a diabetes treatment with the revolutionary side effect of safe,...
View Details
- Web
Asia Pacific - Global
Badaracco, Tom Quinn and John Schultz Danish pharmaceutical company Novo Nordisk was owned by a charitable foundation, and since its founding in the 1920s had focused on producing insulin to treat diabetes. In 2017, however, it released Ozempic, a View Details
- Web
Africa - Global
producing insulin to treat diabetes. In 2017, however, it released Ozempic, a diabetes treatment with the revolutionary side effect of safe, effective weight loss. As demand in the U.S. reached a fever pitch, Novo faced opportunities and...
View Details
- Web
Winners & Success Stories - New Venture Competition
that aims at democratizing chronic care management in the developing world by leveraging the ubiquity of mobile phones and PCs. The team is based in India is currently focused on developing an affordable mobile phone based diagnostic platform for Diabetes. No longer a...
View Details
- Web
Human Behavior & Decision-Making - Faculty & Research
foundation, and since its founding in the 1920s had focused on producing insulin to treat diabetes. In 2017, however, it released Ozempic, a diabetes treatment with the revolutionary side effect of safe, effective weight loss. As demand...
View Details
- Web
CSV in Practice - Institute For Strategy And Competitiveness
Shared Value in Products & Markets Novo Nordisk developed diabetes training programs for Chinese physicians in partnership with government, NGOs, and opinion leaders to disseminate the latest thinking on View Details
- Web
Health Care - Faculty & Research
foundation, and since its founding in the 1920s had focused on producing insulin to treat diabetes. In 2017, however, it released Ozempic, a diabetes treatment with the revolutionary side effect of safe, effective weight loss. As demand...
View Details
- 15 Sep 2021
- Research & Ideas
Don't Bring Me Down: Probing Why People Tune Out Bad News
No one wants to hear that their car exhaust is hurting the planet, or that their jeans were made in a sweatshop, or that their doughnut might give them diabetes one day. In fact, people often go to great lengths to avoid information that...
View Details
Keywords:
by Kristen Senz
- Web
Social Enterprise - Faculty & Research
1920s had focused on producing insulin to treat diabetes. In 2017, however, it released Ozempic, a diabetes treatment with the revolutionary side effect of safe, effective weight loss. As demand in the U.S. reached a fever pitch, Novo...
View Details
- 04 Apr 2024
- News
The Making of a Medical Milestone
On March 16, doctors at the Massachusetts General Hospital made history when they successfully transplanted a kidney from a genetically modified pig to a living human. The groundbreaking procedure marked a significant milestone in animal-to-human transplant, or...
View Details
Keywords:
Margie Kelley
- Web
Globalization - Faculty & Research
2017, however, it released Ozempic, a diabetes treatment with the revolutionary side effect of safe, effective weight loss. As demand in the U.S. reached a fever pitch, Novo faced opportunities and challenges. The case covers the markets...
View Details
- 22 Feb 2022
- Research & Ideas
Lack of Female Scientists Means Fewer Medical Treatments for Women
and women more often than male-led teams do. “Women are more likely to work on topics like endometriosis or cervical cancer, but they're also more likely to find ways to adapt inventions for women in research on conditions like diabetes...
View Details
Keywords:
by Kristen Senz
- Web
Recruiting Partners - Health Care
Pharmaceuticals Amarin Corporation American Tinnitus Association American Well AmerisourceBergen Amgen, Inc. Amicoat AS Amicus Therapeutics Amnisure International LLC Angiogenesis Foundation Antera Therapeutics Apollo Hospitals Arbor Pharmaceuticals Array BioPharma...
View Details
- 01 Oct 2000
- News
Carlos A. Saladrigas: Hardworking Optimist
Vincam became ADP TotalSource, and Saladrigas, as CEO, oversees the company's twenty regional offices and over eighty thousand employees. A Man of the Year award from the Juvenile Diabetes Foundation and an Alumnus of Distinction honor...
View Details
Keywords:
Susan Young
- 02 Jun 2021
- Research & Ideas
A Rare Find in Health Care: A Simple Solution to Racial Inequity
physicians could also provide patients with outcome data for local hospitals, nudging them toward facilities with better track records. Such changes could help not only heart attack patients, but also patients suffering from a wide variety of diseases, including View Details